• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Inappropriate proton pump inhibitor lansoprazole prescription in older adults hospitalized in long-term care unit.不适当的质子泵抑制剂兰索拉唑在长期护理病房住院老年人中的处方。
Ir J Med Sci. 2023 Aug;192(4):1661-1664. doi: 10.1007/s11845-022-03207-3. Epub 2022 Nov 4.
2
The Inappropriate Prescription of Oral Proton Pump Inhibitors in the Hospital Setting: A Prospective Cross-Sectional Study.医院环境中口服质子泵抑制剂的不适当处方:一项前瞻性横断面研究。
Dig Dis Sci. 2015 Aug;60(8):2280-6. doi: 10.1007/s10620-015-3642-8. Epub 2015 Apr 4.
3
The status of proton pump inhibitor use: a prescription survey of 45 hospitals in China.质子泵抑制剂的使用情况:对中国45家医院的处方调查
Rev Esp Enferm Dig. 2019 Oct;111(10):738-743. doi: 10.17235/reed.2019.6155/2019.
4
Low-Value Proton Pump Inhibitor Prescriptions Among Older Adults at a Large Academic Health System.大型学术医疗系统中老年患者质子泵抑制剂的低价值处方
J Am Geriatr Soc. 2019 Dec;67(12):2600-2604. doi: 10.1111/jgs.16117. Epub 2019 Sep 5.
5
Characterizing Potentially Inappropriate Prescribing of Proton Pump Inhibitors in Older People in Primary Care in Ireland from 1997 to 2012.1997年至2012年爱尔兰基层医疗中老年人质子泵抑制剂潜在不适当处方的特征分析
J Am Geriatr Soc. 2016 Dec;64(12):e291-e296. doi: 10.1111/jgs.14528. Epub 2016 Nov 7.
6
Proton pump inhibitor utilisation and potentially inappropriate prescribing analysis: insights from a single-centred retrospective study.质子泵抑制剂的利用与潜在不适当处方分析:来自单中心回顾性研究的见解。
BMJ Open. 2020 Nov 26;10(11):e040473. doi: 10.1136/bmjopen-2020-040473.
7
[Impact of an evaluation of the professional practices on the relevance of proton pump inhibitors prescriptions pertinence at the hospital].[专业实践评估对医院质子泵抑制剂处方相关性的影响]
Rev Med Interne. 2018 Aug;39(8):618-626. doi: 10.1016/j.revmed.2018.03.006. Epub 2018 Apr 5.
8
[Proton-pump inhibitor use and hyponatremia].[质子泵抑制剂的使用与低钠血症]
Nihon Ronen Igakkai Zasshi. 2023;60(2):153-157. doi: 10.3143/geriatrics.60.153.
9
Snapshot of proton pump inhibitors prescriptions in a tertiary care hospital in Switzerland: less is more?瑞士一家三级保健医院质子泵抑制剂处方快照:少即是多?
Int J Clin Pharm. 2019 Dec;41(6):1634-1641. doi: 10.1007/s11096-019-00929-w. Epub 2019 Oct 29.
10
Medication-related factors associated with proton pump inhibitor prescription beyond official guidelines in older adults.与老年人超出官方指南的质子泵抑制剂处方相关的药物相关因素。
Eur Geriatr Med. 2020 Dec;11(6):1051-1061. doi: 10.1007/s41999-020-00380-5. Epub 2020 Aug 17.

本文引用的文献

1
AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review.AGA 临床实践更新:质子泵抑制剂的撤药——专家综述。
Gastroenterology. 2022 Apr;162(4):1334-1342. doi: 10.1053/j.gastro.2021.12.247. Epub 2022 Feb 17.
2
Influence of individual proton pump inhibitors on clinical outcomes in patients receiving clopidogrel following percutaneous coronary intervention.个体质子泵抑制剂对经皮冠状动脉介入治疗后接受氯吡格雷治疗的患者临床结局的影响。
Medicine (Baltimore). 2021 Dec 30;100(52):e27411. doi: 10.1097/MD.0000000000027411.
3
Successful deprescribing of proton pump inhibitors with a patient-centered process: the DESPIBP Project.以患者为中心的质子泵抑制剂成功撤药方案:DESPIBP 项目。
Eur J Clin Pharmacol. 2021 Dec;77(12):1927-1933. doi: 10.1007/s00228-021-03186-x. Epub 2021 Jul 16.
4
Umbrella review of 42 systematic reviews with meta-analyses: the safety of proton pump inhibitors.42 项系统评价和荟萃分析的伞状评价:质子泵抑制剂的安全性。
Aliment Pharmacol Ther. 2021 Jul;54(2):129-143. doi: 10.1111/apt.16407. Epub 2021 Jun 11.
5
Side effects of long-term use of proton pump inhibitors: practical considerations.质子泵抑制剂长期使用的副作用:实际考虑。
Pol Arch Intern Med. 2021 Jun 29;131(6):541-549. doi: 10.20452/pamw.15997. Epub 2021 May 13.
6
[Critical assessment of long-term proton pump inhibitor use in the elderly].[老年患者长期使用质子泵抑制剂的批判性评估]
Rev Med Liege. 2020 Jan;75(1):10-16.
7
Proton Pump Inhibitors in the Elderly, Balancing Risk and Benefit: an Age-Old Problem.老年人使用质子泵抑制剂:权衡风险与获益——一个由来已久的问题
Curr Gastroenterol Rep. 2019 Dec 5;21(12):65. doi: 10.1007/s11894-019-0732-3.
8
American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults.美国老年医学学会 2019 年更新的老年人潜在不适当药物使用 AGS Beers 标准®。
J Am Geriatr Soc. 2019 Apr;67(4):674-694. doi: 10.1111/jgs.15767. Epub 2019 Jan 29.
9
Deprescribing Proton Pump Inhibitors.停用质子泵抑制剂
Can J Hosp Pharm. 2018 Sep-Oct;71(5):291-292. Epub 2018 Oct 31.
10
We have had a gutful: The need for deprescribing proton pump inhibitors.我们受够了:减少质子泵抑制剂处方的必要性。
J Clin Pharm Ther. 2018 Feb;43(1):65-72. doi: 10.1111/jcpt.12613. Epub 2017 Sep 11.

不适当的质子泵抑制剂兰索拉唑在长期护理病房住院老年人中的处方。

Inappropriate proton pump inhibitor lansoprazole prescription in older adults hospitalized in long-term care unit.

机构信息

Long-Term Care Department, Hospital of Paul Doumer, Assistance Publique des Hôpitaux de Paris (AP-HP), Labruyère, France.

Pharmacy Department, Hospital of Paul Doumer, Assistance Publique des Hôpitaux de Paris (AP-HP), Labruyère, France.

出版信息

Ir J Med Sci. 2023 Aug;192(4):1661-1664. doi: 10.1007/s11845-022-03207-3. Epub 2022 Nov 4.

DOI:10.1007/s11845-022-03207-3
PMID:36333472
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10390349/
Abstract

PURPOSE

We evaluated the use of the PPI treatment by physicians in older adults hospitalized in a long-term care unit.

METHODS

We included 40 patients aged 65 years or older with a lansoprazole prescription hospitalized in long-term care unit from January 2018 to January 2022. Patient characteristics, gastroduodenal history, dose of lansoprazole, indication, days of prescription, and number of medications were collected from electronic patient records.

RESULTS

The mean age of patients was 84.2 ± 9.3. Patients were taking between 5 and 24 (mean = 12.7, SD = 4.4) medications overall with 15 patients taking low dose of aspirin (75 mg daily) and 8 patients taking an antiplatelet. Most patients (82.5%) received once-daily lansoprazole treatment, 55% of whom took a dose of 15 mg. Five patients were treated with the maximum dose of lansoprazole 30 mg twice daily. Only seven patients had an appropriate indication. The minimum of treatment time was 3 days and the maximum was 1198 days; moreover, 24 patients (60%) were still in treatment.

CONCLUSION

Few PPI prescriptions had an indication in the patient's electronic record. Prescriptions were ongoing with no date of discontinuation or re-evaluation.

摘要

目的

我们评估了在长期护理病房住院的老年患者中,医生使用质子泵抑制剂(PPI)治疗的情况。

方法

我们纳入了 2018 年 1 月至 2022 年 1 月期间在长期护理病房住院且开具了兰索拉唑处方的 40 名 65 岁及以上的患者。从电子病历中收集了患者特征、胃十二指肠疾病史、兰索拉唑剂量、适应证、处方天数和用药数量等信息。

结果

患者的平均年龄为 84.2±9.3 岁。他们总共服用了 5 至 24 种(平均 12.7,标准差 4.4)药物,其中 15 名患者服用低剂量阿司匹林(每日 75mg),8 名患者服用抗血小板药物。大多数患者(82.5%)接受了每日一次的兰索拉唑治疗,其中 55%的患者服用 15mg 剂量。有 5 名患者接受了兰索拉唑最大剂量(30mg,每日 2 次)治疗。仅有 7 名患者的适应证恰当。治疗时间最短为 3 天,最长为 1198 天;此外,24 名患者(60%)仍在接受治疗。

结论

患者的电子病历中仅有少数 PPI 处方有适应证。处方仍在继续,没有停药或重新评估的日期。